We performed a post hoc secondary analysis in DEFINE-HF to: 1) describe the distribution and correlation of ApoM levels at baseline in the DEFINE-HF population; 2) understand the effect of dapagliflozin on levels of ApoM; and 3) assess the relationship between changes in ApoM and markers of kidney disease and HF. Here, APOM is linked to kidney disorder.